83 related articles for article (PubMed ID: 16532483)
1. Inhibitors of COX activity preserve muscle mass in mice bearing the Lewis lung carcinoma, but not the B16 melanoma.
Graves E; Ramsay E; McCarthy DO
Res Nurs Health; 2006 Apr; 29(2):87-97. PubMed ID: 16532483
[TBL] [Abstract][Full Text] [Related]
2. Conjugated linoleic acid preserves muscle mass in mice bearing the Lewis lung carcinoma, but not the B16 melanoma.
McCarthy DO; Graves E
Res Nurs Health; 2006 Apr; 29(2):98-104. PubMed ID: 16532476
[TBL] [Abstract][Full Text] [Related]
3. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
Benny Klimek ME; Aydogdu T; Link MJ; Pons M; Koniaris LG; Zimmers TA
Biochem Biophys Res Commun; 2010 Jan; 391(3):1548-54. PubMed ID: 20036643
[TBL] [Abstract][Full Text] [Related]
4. Effect of cyclooxygenase and nitric oxide synthase inhibitors on tumor growth in mouse tumor models with and without cancer cachexia related to prostanoids.
Cahlin C; Gelin J; Delbro D; Lönnroth C; Doi C; Lundholm K
Cancer Res; 2000 Mar; 60(6):1742-9. PubMed ID: 10749148
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin preserves muscle mass and reduces levels of E3 ligases and TNF receptor type 1 in the gastrocnemius muscle of tumor-bearing mice.
Hitt A; Graves E; McCarthy DO
Res Nurs Health; 2005 Feb; 28(1):56-66. PubMed ID: 15625704
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
[TBL] [Abstract][Full Text] [Related]
7. Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.
Graves E; Hitt A; Pariza MW; Cook ME; McCarthy DO
Res Nurs Health; 2005 Feb; 28(1):48-55. PubMed ID: 15625711
[TBL] [Abstract][Full Text] [Related]
8. NS-398 treatment after trauma modifies NF-kappaB activation and improves survival.
Mack Strong VE; Mackrell PJ; Concannon EM; Mestre JR; Smyth GP; Schaefer PA; Stapleton PP; Daly JM
J Surg Res; 2001 Jun; 98(1):40-6. PubMed ID: 11368536
[TBL] [Abstract][Full Text] [Related]
9. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
Argilés JM; Figueras M; Ametller E; Fuster G; Olivan M; de Oliveira CC; López-Soriano FJ; Isfort RJ; Busquets S
Muscle Nerve; 2008 Feb; 37(2):190-5. PubMed ID: 17912749
[TBL] [Abstract][Full Text] [Related]
10. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Ding XZ; Tong WG; Adrian TE
Anticancer Res; 2000; 20(4):2625-31. PubMed ID: 10953335
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandins regulate melanoma-induced cytokine production in macrophages.
Eisengart CA; Mestre JR; Naama HA; Mackrell PJ; Rivadeneira DE; Murphy EM; Stapleton PP; Daly JM
Cell Immunol; 2000 Sep; 204(2):143-9. PubMed ID: 11069722
[TBL] [Abstract][Full Text] [Related]
12. Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonist.
Toledo M; Busquets S; Penna F; Zhou X; Marmonti E; Betancourt A; Massa D; López-Soriano FJ; Han HQ; Argilés JM
Int J Cancer; 2016 Apr; 138(8):2021-9. PubMed ID: 26595367
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.
McCarthy DO; Whitney P; Hitt A; Al-Majid S
Res Nurs Health; 2004 Jun; 27(3):174-84. PubMed ID: 15141370
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka H; Tsuji S; Tsujii M; Gunawan ES; Sasaki Y; Kawano S; Hori M
Lab Invest; 1999 Dec; 79(12):1469-77. PubMed ID: 10616198
[TBL] [Abstract][Full Text] [Related]
15. Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia.
Ham DJ; Murphy KT; Chee A; Lynch GS; Koopman R
Clin Nutr; 2014 Jun; 33(3):448-58. PubMed ID: 23835111
[TBL] [Abstract][Full Text] [Related]
16. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival.
Zhou X; Wang JL; Lu J; Song Y; Kwak KS; Jiao Q; Rosenfeld R; Chen Q; Boone T; Simonet WS; Lacey DL; Goldberg AL; Han HQ
Cell; 2010 Aug; 142(4):531-43. PubMed ID: 20723755
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice.
Burleigh ME; Babaev VR; Yancey PG; Major AS; McCaleb JL; Oates JA; Morrow JD; Fazio S; Linton MF
J Mol Cell Cardiol; 2005 Sep; 39(3):443-52. PubMed ID: 16040051
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional induction of cyclooxygenase-2 in osteoblasts is involved in interleukin-6-induced osteoclast formation.
Tai H; Miyaura C; Pilbeam CC; Tamura T; Ohsugi Y; Koishihara Y; Kubodera N; Kawaguchi H; Raisz LG; Suda T
Endocrinology; 1997 Jun; 138(6):2372-9. PubMed ID: 9165025
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of cyclooxygenase inhibitors on the step-through passive avoidance performance in mice treated with NC-1900, an arginine-vasopressin fragment analog.
Ishida T; Sato T; Irifune M; Tanaka K; Hirate K; Nakamura N; Nishikawa T
Methods Find Exp Clin Pharmacol; 2007 Jun; 29(5):315-20. PubMed ID: 17805432
[TBL] [Abstract][Full Text] [Related]
20. Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclooxygenase metabolites in hepatic stellate cells.
Efsen E; Bonacchi A; Pastacaldi S; Valente AJ; Wenzel UO; Tosti-Guerra C; Pinzani M; Laffi G; Abboud HE; Gentilini P; Marra F
Hepatology; 2001 Mar; 33(3):713-21. PubMed ID: 11230753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
